United Therapeutics Earnings
NASDAQ: UTHRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$6.38
United Therapeutics earnings summary
United Therapeutics is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $6.38. In its most recent report on Aug 5, 2026 (Q2 2026), UTHR posted EPS of $7.27. Revenue for the quarter was $783.3 million.
Quarterly EPS is up 13.4% from the same quarter a year earlier. Across the last 16 reports, UTHR shares moved an average of 2.4% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
UTHR earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $7.27 | — | -7.3% |
| May 6, 2026 | — | $5.82 | — | +0.6% |
| Feb 25, 2026 | — | $7.66 | — | -5.1% |
| Oct 29, 2025 | — | $7.16 | — | +0.8% |
| Jul 30, 2025 | — | $6.41 | — | +2.5% |
| Apr 30, 2025 | — | $6.63 | — | +2.3% |
| Feb 26, 2025 | — | $6.23 | — | -1.3% |
| Oct 30, 2024 | — | $6.39 | — | +9.6% |
| Jul 31, 2024 | — | $5.85 | — | +0.8% |
| May 1, 2024 | — | $6.17 | — | +0.7% |
| Feb 21, 2024 | — | $4.33 | — | +2.2% |
| Nov 1, 2023 | — | $5.38 | — | -0.7% |
| Aug 2, 2023 | — | $5.24 | — | +0.6% |
| May 3, 2023 | — | $4.86 | — | -0.0% |
| Feb 22, 2023 | — | $2.65 | — | -0.4% |
| Nov 2, 2022 | — | $4.91 | — | -3.5% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.